Pomdoctor Limited
Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $57.2M |
| Cost of Revenue | $49.7M |
| Gross Profit | $7.5M |
| Gross Margin | 13.1% |
| Operating Expenses | |
| Research & Development | $1.8M |
| SG&A Expense | $8.5M |
| Operating Income | $-17.0M |
| Operating Margin | -29.7% |
| Interest Expense | $563.5K |
| Pretax Income | $-18.7M |
| Income Tax Expense | $54 |
| Net Income | $-18.7M |
| Net Margin | -32.7% |
| EPS (Basic) | $-3.14 |
| EPS (Diluted) | $-3.14 |
| Shares Outstanding (Basic) | 9.7M |
| Shares Outstanding (Diluted) | 9.7M |
| Dividends Per Share | — |